Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

计划入组 8 人 · 首次发布于 2003 年 1 月 27 日

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

计划入组 40 人 · 首次发布于 2003 年 1 月 27 日

Topotecan by Intracerebral Clysis for Recurrent Primary Malignant Brain Tumors

计划入组 16 人 · 首次发布于 2006 年 3 月 29 日

DCVax-Brain

Brain Peptide

Brain-derived neurotrophic factor

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

Brain Sentinel, Inc.

United States

FDA Approves Voranigo: First Targeted Therapy for IDH-Mutant Glioma Brain Cancer

Viva's Portfolio Companies Announce Significant Advances in Biopharmaceutical Innovations

Vorasidenib Approved in China's Boao Lecheng for IDH-Mutant Glioma Treatment